71 related articles for article (PubMed ID: 3864537)
1. Cytogenetics and flow cytometry may predict phenotype of CML blast crisis.
Ligler FS; Brodsky I; Schlam ML; Fuscaldo KE
Cancer Detect Prev; 1985; 8(1-2):317-23. PubMed ID: 3864537
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetics and cell surface marker analysis in CML--1. Prediction of phenotype of acute phase transformation.
Ligler FS; Brodsky I; Schlam ML; Fuscaldo KE
Leuk Res; 1985; 9(9):1093-8. PubMed ID: 3865030
[TBL] [Abstract][Full Text] [Related]
3. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
4. [A "primitive" variant of the blast crisis in chronic myeloleukemia].
Baryshnikov AIu; Turkina AG; Moiseenkova IN; Frolova EA; Sediakhina NP; Diagileva OA; Khoroshko ND; Mokeeva RA
Ter Arkh; 1995; 67(7):22-5. PubMed ID: 7482298
[TBL] [Abstract][Full Text] [Related]
5. Clonal evolution of karyotype in blastic phase of CML.
Izakovic V; Horák I; Krizan P
Neoplasma; 1982; 29(5):613-23. PubMed ID: 6960260
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetics and cell surface marker analysis in chronic myelocytic leukemia. II. Implications for patient management.
Fuscaldo KE; Brodsky I; Crilley P; Ligler FS
Cancer Genet Cytogenet; 1987 May; 26(1):25-37. PubMed ID: 3470134
[TBL] [Abstract][Full Text] [Related]
7. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J
Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
[TBL] [Abstract][Full Text] [Related]
8. Chronic myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
Mesárosová A; Hrivnáková A; Klobusická M; Babusíková O
Neoplasma; 1995; 42(1):9-14. PubMed ID: 7617076
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological features in HLA-DR-negative acute myeloid leukemia].
Muroi K; Yoshida M; Suzuki T; Amemiya Y; Hatake K; Miura Y
Rinsho Ketsueki; 1997 Aug; 38(8):631-7. PubMed ID: 9311267
[TBL] [Abstract][Full Text] [Related]
10. Near haploid cell line in lymphoid blast crisis of Ph1-positive chronic myeloid leukemia.
Kessous A; Colombies P; Pris J; Clement D
Cancer Res; 1980 Apr; 40(4):1354-9. PubMed ID: 6928400
[TBL] [Abstract][Full Text] [Related]
11. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
[TBL] [Abstract][Full Text] [Related]
12. [Cellular immunophenotypes in 97 adults with acute leukemia].
Piedras J; López-Karpovitch X; Cárdenas MR
Rev Invest Clin; 1997; 49(6):457-64. PubMed ID: 9528305
[TBL] [Abstract][Full Text] [Related]
13. [Auer bodies and Ph1 chromosome: chronic myeloid pseudoleukemia?].
Mayer S; Falkenrodt A; Albert A; Audhuy B; Stoll C; Uettwiller F; Oberling F; Bergerat JP
Nouv Rev Fr Hematol (1978); 1982; 24(5):307-12. PubMed ID: 6300758
[TBL] [Abstract][Full Text] [Related]
14. [Cytogenetic study of cell sub-populations in human leukemias (AML, CML) sorted by flow cytometry].
Lacombe F; Belloc F; Bernard P; Dachary D; Boisseau MR
Pathol Biol (Paris); 1988 Jan; 36(1):42-5. PubMed ID: 3283670
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of HLA-DR-negative non-M3 AML].
Mori H; Sakai H; Sanada M; Shimamoto K; Sasaki S; Azuma R; Higuchi T; Harada H; Niikura H; Omine M; Fujita K; Takahashi N
Rinsho Ketsueki; 2007 Jul; 48(7):547-53. PubMed ID: 17695303
[TBL] [Abstract][Full Text] [Related]
16. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
[TBL] [Abstract][Full Text] [Related]
17. Cell population analysis of a heterogeneous blast cell crisis of chronic myelogenous leukemia.
Pedraza MA; Mason D; Doslu FA; Marsh RA; Boblett JP
Diagn Immunol; 1984; 2(1):19-24. PubMed ID: 6594209
[TBL] [Abstract][Full Text] [Related]
18. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
[TBL] [Abstract][Full Text] [Related]
19. [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].
Zhu Y; Xu W; Liu Q; Pan J; Qiu H; Wang R; Qiao C; Jiang Y; Zhang S; Fan L; Zhang J; Shen Y; Xue Y; Li J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):579-82. PubMed ID: 18841577
[TBL] [Abstract][Full Text] [Related]
20. Blast crisis of chronic myelogenous leukemia exhibiting immunophenotypic features of a myeloid/natural killer cell precursor.
Murase T; Suzuki R; Tashiro K; Morishima Y; Nakamura S
Int J Hematol; 1999 Feb; 69(2):89-91. PubMed ID: 10071456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
